GlassScriptPhysician profile
Amna H Khan
NPI 1104850999
$435.88
in general payments reported to CMS, 2019-2025
11 companies · $74.79 in 2025
The $74.79 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2020: $95.26 · 2021: $45.32 · 2022: $21.73 · 2023: $22.86 · 2024: $40.96 · 2025: $74.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $138.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $124.73 | 2021-2025 | Aptima, Thinprep 2000 Processor |
| Pfizer INC. | $57.78 | 2020-2025 | |
| Abbvie INC. | $47.07 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.28 | 2019 | |
| Lupin INC. | $37.65 | 2019-2020 | |
| Ethicon US, LLC | $33.21 | 2020 | |
| Janssen Pharmaceuticals, INC | $22.21 | 2024 | Xarelto |
| Evofem Biosciences, INC. | $21.25 | 2020 | |
| Allergan, INC. | $19.62 | 2019 | |
| Exeltis, USA INC. | $18.75 | 2024 | Slynd |
| Therapeuticsmd, INC. | $15.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amna Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.